Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
26 Sep 2025
// FIERCE PHARMA
https://www.fiercepharma.com/manufacturing/amgen-lays-out-650m-grow-puerto-rico-manufacturing-campus-add-hundreds-jobs
10 Sep 2025
// BIOSPACE
https://www.biospace.com/business/beyond-maritide-amgen-makes-portfolio-play-amid-scrutiny-of-obesity-prospect
09 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amgen-and-kyowa-kirin-announce-top-line-results-from-rocatinlimab-phase-3-ascend-long-term-extension-study-in-adults-with-moderate-to-severe-atopic-dermatitis-302549965.html
09 Sep 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761143
04 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/amgen-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference-302546881.html
03 Sep 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/amgens-stomach-cancer-candidate-takes-turn-attenuated-os-benefits-final-phase-3-analysis
Inspections and registrations
ABOUT THIS PAGE
Amgen Inc is a supplier offers 11 products (APIs, Excipients or Intermediates).
Find a price of AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by Amgen Inc
Find a price of AMG 191 DRUG PRODUCT bulk with DMF offered by Amgen Inc
Find a price of INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by Amgen Inc
Find a price of AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by Amgen Inc
Find a price of AMG 282 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find a price of AMG 191 DRUG SUBSTANCE bulk with DMF offered by Amgen Inc
Find a price of HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by Amgen Inc
Find a price of BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by Amgen Inc
Find a price of HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by Amgen Inc
Find a price of Carfilzomib bulk offered by Amgen Inc
Find a price of Recombinant Human Growth Hormone bulk offered by Amgen Inc